Navigating STI & AMR Trends: Implications for Public Health, Diagnostics, and Treatment

The rising prevalence of sexually transmitted infections (STIs) and antimicrobial resistance (AMR) presents significant challenges to public health, necessitating robust policies and advanced diagnostic strategies. This presentation will explore the intersection of STI and AMR trends, emphasizing their impact on public health initiatives and the critical role of diagnostic tools in identifying key resistance mutations. We will highlight recent advancements in diagnostic technologies that enable accurate and timely detection of STIs and AMR, improving clinical decision-making and potential patient outcomes. Additionally, key data and insights will be shared to underscore the importance of refining diagnostic strategies, particularly addressing the underdiagnosis of Mycoplasma genitalium (Mgen) and its clinical implications. By bridging diagnostic innovation with public health policy, we aim to support a more effective response to the evolving STI and AMR landscape.

 

Learning Objectives